Relate
CF; Cystic Fibrosis Research Directions; Fibrocystic Disease of Pancreas; Mucoviscidosis |
TOBI | |
|
A common hereditary disease in which exocrine (secretory) glands produce abnormally thick mucus. This mucus can cause problems in digestion, breathing, and body cooling.
|
Tobi also known as Touba is the fifth month of the Coptic calendar. It lies between January 9 and February 7 of the Gregorian calendar. The month of Tobi is also the first month of the Season of 'Proyet' (Growth) in Ancient Egypt, where the Nile floods recede and the crops start to grow throughout the land of Egypt. The name of the month of Tobi comes from Amso Khem, a form of the Ancient Egyptian God Amun Ra.
|
Cystic Fibrosis as related to Tobramycin Inhalation Solution
- Tobi - Information About the Inhaled Antibiotic Tobi
Tobi is an antibiotic used to treat Pseudomonas aeruginosa, a bacteria that grows in the lungs of many people with cystic fibrosis. Learn what you need to know about ...
- Aztreonam for Inhalation Solution (AZLI) vs Tobramycin ...
Aztreonam for Inhalation Solution (AZLI) vs Tobramycin Inhalation Solution (TOBI®) in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa ...
- Efficiency of Pulmonary Administration of Tobramycin Solution ...
Study objectives: To determine whether tobramycin solution for inhalation (TSI) can be administered ... Setting: Nine US cystic fibrosis (CF) centers. Patients: Fifty-three ...
- Gilead's Head-to-Head Study of Cayston® Versus Tobramycin ...
Gilead's Head-to-Head Study of Cayston® Versus Tobramycin Inhalation Solution in Cystic Fibrosis Patients Achieves Co-Primary Efficacy Endpoint of Non-Inferiority ...
- Gilead's Head-to-Head Study of Cayston® Versus Tobramycin ...
... trial of Cayston®(aztreonam for inhalation solution) versus tobramycin inhalation solution (TIS) in cystic fibrosis (CF) patients with Pseudomonas ...
- Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin ...
Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis (EAGER) This study has been completed. ...
- Gilead's Head-to-Head Study Of Cayston® Versus Tobramycin ...
Gilead's Head-to-Head Study Of Cayston® Versus Tobramycin Inhalation Solution In Cystic Fibrosis Patients Achieves Co-Primary Efficacy Endpoint Of Non-Inferiority ...
- Cystic Fibrosis Clinical Research Trials | CenterWatch
Clinical Research Trial Listings for Cystic Fibrosis in Pulmonary, Respiratory Diseases on CenterWatch
- Cystic Fibrosis Clinical Trial: Amiloride Solution and ...
The purpose of this research study is to determine if multiple doses of two inhaled drugs will help Cystic Fibrosis patients whose lungs are infected with a bac...
- Gilead's Cayston® Superior To Tobramycin Inhalation Solution ...
Gilead Sciences, Inc (Nasdaq:GILD) today announced that its head-to-head Phase III clinical trial of Cayston ® (aztreonam for inhalation solution) versus tobramycin ...
- Home Page
TOBI® (Tobramycin Inhalation Solution, USP) is a prescription inhaled medication for cystic fibrosis patients whose lungs contain bacteria called ...
- Gilead s Head-to-Head Study of Cayston Versus Tobramycin ...
Gilead s Head-to-Head Study of Cayston Versus Tobramycin Inhalation Solution in Cystic Fibrosis Patients Achieves Co-Primary Efficacy Endpoint of Non-Inferiority
- Inhalation Powder Tobramycin for Cystic Fibrosis
ATS 2009: Inhalation Powder Tobramycin Safe, Effective to Treat ... Cystic fibrosis is a tough disease, but patients don't recognize how bad it can be," he ...
- BioMed Central | Full text | Adherence with tobramycin ...
Characteristics of cystic fibrosis study population receiving tobramycin inhalation solution, N = 804. ... Tobramycin inhaled solution utilization in cystic fibrosis patients ...
- TOBI Solution for Inhalation (Chiron), Drug Reference ...
TOBI Solution for Inhalation (Chiron), Drug Reference Encyclopedia - Physicians PDR ... TOBI is indicated for the management of cystic fibrosis patients with P. aeruginosa. ...
- GILEAD S HEAD TO HEAD STUDY OF CAYSTON® VERSUS TOBRAMYCIN ...
Gilead?s Head-to-Head Study of Cayston® Versus Tobramycin Inhalation Solution in Cystic Fibrosis Patients Achieves Co-Primary Efficacy Endpoint of Non-Inferiority ...
- Tobi (Tobramycin Inhalation) - Drug Info, Side Effects ...
Tobi (Tobramycin Inhalation) - Drug Info, Side Effects, Research, Clinical Trials ... Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and ...
- Gilead's Cayston Superior to Tobramycin Inhalation Solution ...
Oct 21, 2010 - Gilead Sciences, Inc. (Nasdaq GILD) today announced that its head-to-head Phase III clinical trial of Cayston (aztreonam for inhalation solution)
- (Tobramycin Summary)
Tobramycin solution for inhalation is indicated for the management of cystic fibrosis patients. colonised with Pseudomonas aeruginosa in patients aged six years and over. ...
- Gilead's Cayston® Superior to Tobramycin Inhalation Solution ...
Gilead's Cayston® Superior to Tobramycin Inhalation Solution in Six-Month Head-to-Head Cystic Fibrosis Study. October 21, 2010 11:53 AM Eastern Daylight Time ...

Not Signed In -
